• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Psychiatry

Mindfulness-Based Interventions May Be Comparable to Cognitive Behavioural Therapy At Improving ADHD-related Symptoms

byUsamah BhaiduandFlaviu Trifoi
March 8, 2024
in Psychiatry, Wellness
Reading Time: 2 mins read
AAP recommends focus on nutrient-rich foods in schools
Share on FacebookShare on Twitter

1. MYmind (a mindfulness-based therapy program) is comparable to cognitive behavioural therapy in improving attention scores in youths.

2. There were small to moderate improvements in behaviour, executive function, and overall well-being within treatment groups.

Evidence Rating Level: 1 (Excellent)

Attention deficit hyperactivity disorder (ADHD) is one of the most common disorders affecting school-aged children with a prevalence of 9-15%. The mainstay management for ADHD may involve both pharmacotherapy and behavioural therapy. However, mindfulness therapies have not been adequately compared to evidence-based therapies in the management of ADHD. The purpose of this study was to fill in this specific gap.

This randomized control trial (RCT) compared MYmind to cognitive behavioural therapy (CBT) to improve ADHD symptoms in children aged 8-12 in Hong Kong. MYmind is an 8-week mindfulness-based therapy program. In this RCT, 69 youths were randomized to the MYmind group and 69 youths were randomized to the CBT group. Children aged 8-12 with a confirmed diagnosis of ADHD based on DSM-5 criteria, who had a normal cognitive function, and who were either on no pharmacotherapy or on the same medication for 3 months were included. Children who could not speak Cantonese, who had previously participated in a mindfulness-based therapy, or who had a severe conduct disorder, other behavioural disorders, or another psychiatric or medical illness that prevented them from participating in the study were excluded. Participants were assessed before treatment, immediately after treatment, 3 months post-treatment, and finally 6 months post-treatment. Attention was assessed using the Sky Search subtest of the Test of Everyday Attention for Children (TEA-Ch). Behaviour, executive function, mindfulness, and overall well-being were also assessed using various recognized inventories. The primary outcome measured was the attention score based on TEA-ch. The secondary outcomes measured improvement in behaviour, executive function, and overall well-being.

The results found MYmind to be comparable to CBT in improving attention scores in youths with ADHD. Within-group data showed significant improvement in secondary outcomes, however MYmind was not shown to be superior to CBT concerning these outcomes either. A limitation of this study is that the study was carried out during the peak of the COVID-19 lockdowns and social unrest. This affected thorough follow-up and required the researchers to carry out some interventions over Zoom. However, this is the largest RCT carried out comparing mindfulness therapy to an evidence-based technique. The future of this research may involve performing a larger non-inferiority study, with longer post-treatment follow-up to assess the stability of outcomes post-intervention. Depending on future findings, mindfulness-based techniques may prove to be an adjunct or alternative therapy in the management of ADHD in youths.

RELATED REPORTS

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

A digital mental health intervention may improve anxiety in breast cancer survivors

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

Click here to read this study in Psychotherapy and Psychosomatics.

Image: PD

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: ADHDappCBTmental healthmindfulness
Previous Post

Palliative care services are underutilized at end of life in Ontario, Canada

Next Post

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

RelatedReports

Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

A digital mental health intervention may improve anxiety in breast cancer survivors

July 31, 2026
Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
Chronic Disease

Medical or procedural abortion may not increase risk of psychotropic medication use after five years

July 27, 2026
Chronic Disease

Behavioral support does not improve patient-directed opioid tapering success

July 6, 2026
Next Post
#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

#VisualAbstract: Inhibition of CD40L with Frexalimab in Multiple Sclerosis Reduces the Number of New Gadolinium-Enhancing T1 Weighted Lesion

Blood type correlates with egg reserve in infertile women

Elafibranor associated with biochemical response in patients with primary biliary cholangitis

Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription

Cefepime-taniborbactam is superior to meropenem in treating complicated urinary tract infections

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
  • Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance
  • Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.